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Engineering and §Departments of Computing Science and Biological Sciences, University of Alberta, Edmonton, Alberta, CanadaABSTRACT Amyloid ﬁbrils are associated with many neurodegenerative diseases. It was found that amyloidogenic oligomers,
not mature ﬁbrils, are neurotoxic agents related to these diseases. Molecular mechanisms of infectivity, pathways of aggregation,
and molecular structure of these oligomers remain elusive. Here, we use all-atom molecular dynamics, molecular mechanics
combined with solvation analysis by statistical-mechanical, three-dimensional molecular theory of solvation (also known as
3D-RISM-KH) in a new MM-3D-RISM-KH method to study conformational stability, and association thermodynamics of small
wild-type Ab17–42 oligomers with different protonation states of Glu
22, as well the E22Q (Dutch) mutants. The association
free energy of small b-sheet oligomers shows near-linear trend with the dimers being thermodynamically more stable relative to
the larger constructs. The linear (within statistical uncertainty) dependence of the association free energy on complex size is
a consequence of the unilateral stacking of monomers in the b-sheet oligomers. The charge reduction of the wild-type Ab17–42
oligomers upon protonation of the solvent-exposed Glu22 at acidic conditions results in lowering the association free energy
compared to the wild-type oligomers at neutral pH and the E22Q mutants. The neutralization of the peptides because of the
E22Qmutation only marginally affects the association free energy, with the reduction of the direct electrostatic interactions mostly
compensated by the unfavorable electrostatic solvation effects. For the wild-type oligomers at acidic conditions such compensa-
tion is not complete, and the electrostatic interactions, alongwith the gas-phase nonpolar energetic and the overall entropic effects,
contribute to the lowering of the association free energy. The differences in the association thermodynamics between thewild-type
Ab17–42 oligomers at neutral pH and the Dutchmutants, on the one hand, and the Ab17–42 oligomers with protonated Glu
22 , on the
other, may be explained by destabilization of the inter- and intrapeptide salt bridges between Asp23 and Lys28. Peculiarities in the
conformational stability and the association thermodynamics for the different models of the Ab17–42 oligomers are rationalized
based on the analysis of the local physical interactions and the microscopic solvation structure.INTRODUCTIONAmyloid fibrils are associated with many neurodegenerative
diseases, including Alzheimer’s, Parkinson’s, and prion
diseases (1,2). Resolving the molecular structure and under-
standing the molecular mechanisms of formation of neuro-
toxic amyloidogenic oligomers and amyloid fibrils are crucial
for earlier diagnostics and prevention of such diseases. It
has been observed in the x-ray scattering experiments that
amyloid fibrils are characterized by cross-b structural motif
(3), but until recently, only low-resolution structures of
fibrils were available. The studies on the yeast prion protein
Sup35 (4) and short fragments of other proteins (5) unveiled
a possible molecular structure of amyloid fibrils. The molec-
ular models of amyloid (A)b fibril associated with Alz-
heimer’s disease have been proposed based on solid-state
nuclear magnetic resonance experiments (6,7) and hydrogen/
deuterium-exchange nuclear magnetic resonance combined
with mutagenesis studies (8).
Mechanisms of amyloidogenesis are well studied for
a number of amyloidogenic proteins (1,9,10). Recently, direct
experimental measurements of kinetic and thermodynamicsSubmitted May 30, 2008, and accepted for publication September 17, 2009.
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0006-3495/10/01/0282/15 $2.00of amyloid formation became possible (11). At the same
time, the molecular details of the process of the fibril forma-
tion remain elusive. The experimental data suggest that there
are two distinct stages in the fibril growth (1,12,13). At the
first, nucleation stage, amorphous nontoxic aggregates could
be formed. The aggregation of misfolded proteins also results
in formation of globular oligomers (or protofibrils) (1), and
they may transform into amyloid fibrils. These globular olig-
omers can be regarded as a precursor state for mature fibrils.
Their molecular structure is unknown, but based on their
toxicity and ability to seed fibrilization, it was suggested
that there may be a similarity in the structure between
some toxic oligomers and amyloid fibrils (14). The nucleation
stage of amyloidogenesis is followed by the elongation
stage, where the intermediate oligomeric aggregates with the
b-sheet structure grow and transform into a mature fibril.
These two stages of amyloid formation have been recently
observed and investigated in computer modeling of the
protein aggregation process (15) based on the tube model of
protein (16), and the nucleation barriers for aggregation and
fibril elongation have been characterized.
The stability and propensity for aggregation of Ab
peptides constituting Ab fibril are significantly affected by
the (familial) point mutations. The effects of mutationsdoi: 10.1016/j.bpj.2009.09.062
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omerization and fibril formation using various computational
approaches. Initial misfolding and conformation dynamics of
Ab monomers were analyzed, based on all-atom explicit
solvent molecular dynamics (MD), Monte Carlo methods,
and coarse-grained models (17–23). It was found, for
example, that the difference in the oligomerization propen-
sity for different mutants can be related to the change in
stability of Ab peptides upon mutation (17,18,22,23). This
finding is in agreement with the recent experimental studies
on the familial mutations of Ab peptides (24). Another set of
the theoretical works have been focused on the properties of
Ab oligomers. Because their structure remains unknown, the
dynamics and thermodynamic of Ab aggregates have been
analyzed for the b-sheet oligomers modeled after the frag-
ment of mature fibril (21,25–31). Most of these studies relied
on the recently proposed high-resolution molecular models
of Ab1–40 (6,7) and Ab1–42 (8) fibrils. Such b-sheet oligo-
mers can be possibly generated in vivo or in vitro by frag-
mentation of the mature fibril. It was recently found that
Ab dimer (with the still unknown molecular structure) is
the smallest neurotoxic agent in the Alzheimer’s disease,
and such dimers may be released by the amyloid fibril
(32). One may speculate that after dissociation from the
fibril, small oligomers may initially preserve their cross-
b structure, with further major structural reconstruction.
The accuracy of this hypothesis has yet to be confirmed,
but the analysis of dynamics and thermodynamic stability
of b-sheet oligomers has been proven to provide an impor-
tant insight into the pathways of oligomerization and to assist
in modeling of the structure of Ab oligomers (21,25–31).
In this article, we focus on the comparative study of the
association thermodynamics and conformational stability
of the b-sheet wild-type Ab17–42 oligomers with the different
charge state of solvent-exposed Glu22, and the E22Q (Dutch)
mutants. The E22Q mutation (33,34) substitutes the polar
(negatively charged at neutral pH) glutamic acid with the
polar (neutral) glutamine residue at position 22 in the Ab
peptide, which reduces its charge. The Dutch E22Q mutants
are characterized by higher oligomerization propensity and
fibril elongation rate, compared to the wild-type Ab peptides
(13,35–39), and the Dutch mutation may promote stability of
Ab1–40 aggregates (13). It was proposed that the reduction
in the direct electrostatic interactions upon mutation can
destabilize the turn (Val24-Gly25-Ser26-Asn27) in the Ab
monomers, which makes them less stable, and promote the
aggregation (17,24). In addition, the decrease in the electro-
static penalty may be a favorable factor in the oligomeriza-
tion process after the initial conformational change of the
monomer (21–24). For the wild-type (WT) peptides, a similar
alternation of the charge state at position 22 can be due to
protonation of the glutamic acid residue upon lowering
solvent pH. It was proposed in Massi et al. (22) that the fibril
elongation rate for the WT and the Dutch mutant peptides
may be similar under acid conditions. The analysis of pKaof the protonatable residues shows that for pH 4 and below,
solvent-exposed Glu22 residues will be protonated. The
comparison of the thermodynamic properties of the E22Q
mutants and the WT assemblies at pH 4 is of interest because
of their similarity regarding the direct electrostatic interac-
tions. We note that at pH 4 the oligomerization may proceed
through a different route, compared to the neutral solvent
environment, and the resulting morphology of the oligomers
or fibrils may be different from that corresponding to the WT
pH 7 or the Dutch mutant cases (40).
Solvation effects play a significant role at different stages
of formation of prefibrillar oligomers and amyloid fibrils.
Theoretical description of solvation effects requires statis-
tical mechanical approaches to the solvation structure and
thermodynamics. All-atom explicit solvent MD can be
referred to as a first-principle approach to the structural
and thermodynamic properties of biomolecular systems
(41). MD methods have been used to study different aspects
of amyloidogenesis, from unfolding of amyloidogenic pro-
teins to oligomerization and fibril formation (17–23,
25–29,42–57). Study of the thermodynamics of oligomeriza-
tion and formation of amyloid fibrils using the MD simula-
tion approach has been significantly impeded by the
enormous complexity of the problem. First of all, the thermo-
dynamic analysis of large aggregates of proteins is a notori-
ously computationally demanding problem. Even modern
powerful computers do not allow one to simulate, from the
first principles, the effects of solvation on aggregation, fibrili-
zation, and stability of oligomers and amyloid fibrils, with
systematic accounting for solvent composition and its proper-
ties such as level of pH and salt concentration. Decomposition
of the free energy (including the solvation part) into its phys-
ical components, such as entropic and enthalpic, electrostatic
and nonelectrostatic, which provides essential information on
mechanisms of proteins folding and aggregation, is currently
also impractical inMD simulations (and indeed unfeasible for
large protein aggregates in realistic systems), both with
explicit and implicit solvation models. In the latter case, the
nonelectrostatic interactions, and thus, hydrophobic effects
which are crucial for correct explanation of the mechanisms
of misfolding and aggregation of amyloidogenic proteins,
cannot be accounted for in a properway (58,59). Additionally,
the MD description of solvent molecules buried inside the
protein folds and possibly localized in the core of amyloid
fibrils at the different stages of thematuration process requires
modeling of nonequilibrium events of folding/unfolding and
aggregation to allow the solvent molecules to penetrate the
structure. This is a challenging problem for currentMD simu-
lations for large biomolecular systems.
The above explains why there has been no thorough study
of solvation effects so far, despite the importance of solva-
tion effects for the pathways of misfolding and aggregation
of amyloidogenic peptides. Here, making the first step in
this direction, we present a comprehensive analysis of the
association thermodynamics, including the solvation effectsBiophysical Journal 98(2) 282–296
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with pronounced b-sheet structure, obtained by fragmenta-
tion of mature fibril. We achieve that by employing the statis-
tical-mechanical, three-dimensional molecular theory of
solvation (60), also known as 3D-RISM-KH approach. The
method has proven to be successful in the description of the
solvation structure and thermodynamics of proteins and pro-
tein complexes under different solvent conditions (61–70).METHODS
Free energy calculations
The free energy of a macromolecule in solution can be represented as an
average over all possible conformations sampled from the canonical distri-
bution (71),
DG ¼ DHgas
 þ DGsolv
 TDSconf

; (1)
where the first two terms give the effective energy of a macromolecule in
solution (71,72), and the last term is the contribution to the free energy
due to the macromolecule conformational entropy. The gas-phase internal
energy includes the bonded (bond, angle, and torsion angles) and nonbonded
(the van der Waals or dispersion, and the electrostatic) interactions. The
solvation free energy, DGsolv, is the free energy change upon transfer of
the solute molecule from vacuum to solvent. It describes all the solvation
effects, including those due to the solvation energy and entropy. The angle
brackets denote the average over conformations sampled from the canonical
distribution for the solute-solvent system at given temperature T, using the
MD or Monte Carlo methods. The above equation is a theoretical basis
for the molecular mechanics-Poisson-Boltzmann/Surface Area (MM-PB/
SA) approach for calculation of the free energy of macromolecules in solu-
tion (73–76), as implemented in the AMBER MD package (77). The
approach was previously used to study the thermodynamics of amyloido-
genic peptides in Ding et al. (78).
There is growing evidence that the continuous solvation models, such as
the Poisson-Boltzmann approach combined with the solvent-accessible
surface area (SA) term to account for the nonpolar interactions, cannot
describe the nonelectrostatic effects accurately (58,59,74), especially for
small proteins. This follows from the fact that for small peptides there is
no proportionality between solvent-accessible surface area of a protein
and the nonpolar part of the solvation free energy (79). In addition, such
models do not account correctly for the dispersion interactions and excluded
volume effects (58,59). This raises questions about their applicability to
describe quantitatively the hydrophobic effects, which are of paramount
importance for understanding the molecular mechanisms of misfolding
and aggregation of amyloidogenic proteins (15). Here, to account accurately
for nonpolar effects on the association thermodynamics of Ab17–42 peptides,
we propose the following combined approach. We use molecular dynamics
(MD) to generate trajectories, followed by molecular mechanics (MM) to
calculate the peptides internal energy and conformational entropy and the
three-dimensional molecular theory of solvation to characterize the solvation
free energy. It worth noting that the continuous solvation models, such as the
Poisson-Boltzmann or generalized Born methods combined with the
solvent-accessible surface area nonpolar term, require the phenomenological
parameters (ionic radii, the surface tension coefficients) to be used as input
for modeling (74), which makes them less reliable, compared to the molec-
ular theory of solvation.
Following the same lines as in the original implementation of the
MM-PB/SA approach, we first performed all-atom explicit solvent MD
simulations for Ab17–42 oligomers of different sizes. Then, the gas-phase ener-
gies and the conformation entropy of the oligomers were found using the
sander and nmode modules of the AMBER 9 molecular dynamics package
(77) (theMMpart of the simulations). The solvation free energy and its compo-Biophysical Journal 98(2) 282–296nents were obtained using the 3D-RISM-KH approach (60). The combination
of theMMand themolecular theory of solvationwill be referred to as theMM-
3D-RISM-KH method. The approach is currently being implemented in the
AMBER package (80) and will be available in its new releases.
Molecular dynamics simulations and energy
minimization
MD trajectories for free energy calculations were obtained from the all-atom
explicit solvent molecular dynamics simulations using the AMBER 9
molecular dynamics package (77) with the ff99 protein force field (81).
As a starting conformation for modeling, the experimental structure of the
fragment of Ab fibril (Protein Data Bank ID code 2BEG (8), model 1)
was used. The fragment consists of five Ab (1–42) peptides (8) labeled A,
B, C, D, and E. To avoid conformational bias we analyzed only the part
of the fragment with the well-defined secondary structure that corresponds
to residues from 17 to 42 for each Ab peptide. Their coordinates were taken
from the PDB file. The similar construct was recently used for modeling the
Alzheimer fibril architecture (25). The initial structure for Ab17–42 pentamer
comprised all five chains (from A through E) of the experimental structure.
As a representative (starting) conformation for Ab17–42 monomer, chain C
was used. The initial structures for other complexes were made of chains
B and C in the case of a dimer, chains B, C, and D for a trimer, and from
chains B, C, D, and E for a tetramer. The initial structures for the Dutch
mutants were obtained by the E22Q substitution using the AMBER 9 molec-
ular dynamics package (77). To simulate the solvent acidic condition at
pH 4, we first found the change in the charge state of the Ab17–42 peptides
upon lowering the pH. We used the PROPKA 2.0 software (82) to obtain
pKa values of the protonatable residues. Then, based on this information,
we updated the charge states of these residues. The pKa values of the
solvent-exposed glutamic acids Glu22 fall into the range between 4.5 and
4.8, which allowed us to suggest that lowering the level of pH below 4.5
will result in protonation of these residues. Because pKa values for all other
solvent-exposed residues are >7 or <4, there will be no further changes of
the protonation states of the peptides. Protonation of the solvent-exposed
glutamic acids results in neutralization of each peptide. Thus, the interval
of pH between 4 and 4.5 corresponds to the isoelectric point of the Ab17–42
peptides as it is predicted by the PROPKA algorithm (82). We note that the
structure of the amyloid fibril and the pathways of oligomerization may be
different at low pH conditions compared to both the wild-type at the neutral
pH and the E22Q mutant cases, and the above models were used only as
initial conformations for the molecular dynamics simulations.
In all MD simulations, the following protocol was used. In the WT pH 7
case, the sodium counterions were added with the AMBER package at the
points of the lowest electrostatic potential to compensate nonzero charges
of peptides (1e per monomer, where e is the elementary charge). The initial
structures were solvated with SPC/E (83) water molecules in a rectangular
periodic box. A distance of at least 20 A˚ was allowed between the peptides
and periodic boundaries to avoid any bias due to the periodicity of the simu-
lation box. The number of water molecules added varied from 9910 (in the
case of the monomer) to 12,825 (for the pentamer). The above procedure
was followed by two minimization runs. In the first run, to relax solvent,
we used 5000 steps of the steepest descent method followed by 5000 steps
of the conjugate gradient method, keeping peptides’ degrees of freedom
restrained. In the second run, an additional 5000 of the steepest descent
cycles were used to relax the peptides’ degrees of freedom. For the mini-
mized systems, the root mean-square (RMS) of the energy gradient
was <0.015 kcal/(mol A˚).
The production MD simulations were preceded by two thermalization/
equilibration runs. First, the temperature was gradually raised from 0 to
298.15 K and the system was thermalized for 50,000 MD steps. Then,
another portion of 50,000 MD steps at constant pressure were used to relax
the solvent degrees of freedom and to adjust the solvent density to ~1 g/cm3.
For pressure regulation, the isotropic position scaling was used with the
pressure relaxation time of 1 ps1. In both equilibration runs the peptides
coordinates were restrained to their minimum energy values. The MD
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atoms were constrained with the SHAKE algorithm (84), which allowed
us to set the MD step to 2 fs. Langevin dynamics was used for temperature
control with the collision frequency of 5 ps1. The cutoff for nonbonded
interactions was 16 A˚. The other parameters in sander were set to their
default values.
For the free energy calculations, snapshots were taken every 20 ps from
a 0.5-ns stretch of themetastable part of theMD trajectories for each complex.
These snapshots were then used to find averages of the free energy compo-
nents, according to Eq. 1. The number of snapshots taken for postproduction
analysis was limited by the computational time of this approach. The most
time-consuming parts are calculations of the conformational entropy of
peptides using module nmode from the AMBER 9 molecular dynamics
package (77) and of the solvation free energy (and its breakdown into
energetic and entropic components) using the three-dimensional molecular
theory of solvation. To verify the approach we also calculated the gas-phase
energies of peptides using all 2500 snapshots taken from the same parts of the
trajectories. The deviations from the partial average were <1–11 kcal/mol,
depending on the oligomer size. This is less than the standard deviation for
any component of the free energy. Additionally, calculations of the free
energy were carried out, based on the sets of snapshots selected with different
clustering algorithms implemented in ptraj module from the AMBER 10
molecular dynamics package. The averages obtained using different tech-
niques agree within 3–7 kcal/mol, depending on the oligomer size. Thus,
the number of representative snapshots used for analysis was large enough
to control the standard error at the appropriate level.
Three-dimensional molecular theory of solvation
The molecular theory of solvation is based on the formally exact formula-
tion of the statistical mechanics in terms of integral equations for density-
density correlation functions for all components of a system (85). As
required for any analytical theory, it requires some approximations before
it can be used as a practical tool in biosimulations. The reference interac-
tion site model (RISM) theory in its classical formulation (86,87) allows
one to reduce dimensionality of the theory, reformulating it in terms of
one-dimensional correlation functions. This approach has been used
successfully to describe thermodynamic and structural properties of molec-
ular and atomic liquids and mixtures of a given composition, including
electrolyte solutions (87). Its three-dimensional extension (3D-RISM)
(60,88,89) successfully predicts the solvation structure, thermodynamics,
and volumetrics of numerous macromolecules, especially for those of
proteins in solution (60–70). A key component of the theory is a closure
relation complementing the integral equation for the solute-solvent site
total and direct distribution functions. In our study, we employ the approx-
imation proposed by Kovalenko and Hirata (3D-KH closure) (60,89),
which has been proven to be appropriate for complex systems with strong
charges and associating bonds, including proteins in aqueous solutions
(60–70,90). The accuracy of the approach is comparable with all-atoms
explicit solvent simulations of the solvation free energy. In contrast to
the implicit solvation models, such as the Poisson-Boltzmann or its approx-
imation by the generalized Born model (often combined with the solvent
accessible surface term to account for the nonelectrostatic interactions),
the 3D-RISM approach treats both the electrostatic and nonelectrostatic
interactions on the same footing, much as all-atoms molecular simulations
with explicit solvent do. It worth mentioning that the nonelectrostatic inter-
actions are related to the hydrophobic effects, and thus their accurate
description is crucial for understanding of the molecular mechanisms of
fibrilization. An attractive feature of the theory is that it analytically yields
the solvation thermodynamics and volumetrics, including the solvation
entropy (60). What makes this method unique in biomolecular simulations
is the possibility to correctly account, from the statistical mechanical prin-
ciples, for solvent molecules trapped inside biomolecular complexes (62).
Such localized pockets of solvent are of paramount importance for stability
of aggregates of proteins, but in many cases cannot be adequately described
in explicit solvent molecular dynamics simulations, because allowing thesolvent molecules into the protein cavity requires simulating a complete
refolding event.
The method we use in this study and its application for proteins have been
reviewed elsewhere (60,65), and we provide a brief description of the
approach in the Supporting Material. The theory yields complete informa-
tion on the solvation thermodynamics, including the solvation free energy,
DGsolv, and solvent distributions around proteins. To get insight into thermo-
dynamic stability of small Ab oligomers, we decompose the solvation
free energy into the energetic and entropic components (65,91), DGsolv ¼
DEsolv TDSsolv. The hydration entropy DSsolv (in NVT ensemble) is calcu-
lated as the temperature derivative of the solvation free energy at constant
solvent density, DSsolv ¼ (vDGsolv/vT)r.RESULTS AND DISCUSSION
Conformational stability of Ab17–42 oligomers
Even for small peptides, many different folding (unfolding)
pathways exist which may span over a microsecond time-
scale (92). For Ab21–30 monomers, for example, it was found
in all-atom explicit solvent simulations that the major
conformational changes occur on the timescale of hundreds
of nanoseconds (18). The process of dissociation of small
b-sheet oligomers are characterized by similar timescales,
as observed in the MD study of the stability of Ab oligomers
with b-sheet structure (28,29). Thus, for the small Ab17–42
complexes studied in this article, the dissociation (associa-
tion) and refolding times may exceed the microsecond scale.
Full conformational sampling for such systems with avail-
able computational resources is currently unfeasible. At the
same time, the dynamics on the shorter time intervals may
be characterized by dynamically metastable states associated
with different basins of the energy landscape, and thus it
provides useful insight into particular stages of oligomeriza-
tion. In addition, the balance between components of the
free energy derived from the relatively short (compared to
the timescale of folding/association event) MD simulations
gives important quantitative information about the driving
forces behind the association of Ab peptides and the molec-
ular mechanisms of the thermodynamic/dynamic stability of
oligomers. The main goal of our study is to elucidate these
mechanisms for small b-sheet oligomers obtained by frag-
mentation of the mature Ab fibril, with special emphasis
on the solvation effects—in particular, for those of solvation
entropy.
The conformational changes of the oligomers in the course
of the MD simulations were monitored by the root mean-
square displacements (RMSDs) and mean-square fluctua-
tions (MSFs) of the backbone atoms (Figs. 1 and 2). The
RMSDs provide useful information on relative stability of
the oligomers, and were previously used in stability analyses
of Ab oligomers with b-sheet structure (25,27,28,42).
Because the starting conformations were modeled after the
fragment of the mature fibril and which, thus, are not true
(experimental) structures of small Ab oligomers, the recon-
struction of the complexes took place at the beginning of
the production MD runs. In agreement with the previousBiophysical Journal 98(2) 282–296
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FIGURE 1 Root mean-square displacements of the backbone atoms from
the initial structures in the production MD simulations for the wild-type
Ab17–42 monomer, dimer, trimer, tetramer, and pentamer with the charge
state corresponding to neutral pH. (Vertical lines) Dynamically metastable
parts of the trajectories used for the free energy calculations. Conformational
changes monitored by the RMSDs demonstrate a similar dependence on the
system size for the WT pH 4 and the E22Q mutants.
286 Blinov et al.studies, we found that the extent of the conformational
changes strongly depends on the complex size. The most
dramatic changes occur for the monomers, followed by those
for the dimers and trimers. For the larger constructs, less
significant distortion of the initial b-structure was observed
on the timescale of the simulations. After ~2 ns of MD runs,
the RMSDs for the monomers and dimers reach plateaus that
can be regarded as the signature of a dynamically metastable
state. The conformational fluctuations (as seen from RMSDs
and MSFs) are still significant, but they take place around17 27 37 48 58 68 79 89 100 110 120
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FIGURE 2 Mean-square fluctuations (B-factors) of the a-carbon atoms on
a per-residue basis for thewild-typeAb17–42monomer, dimer, and tetramer at
neutral pH. B-factors are normalized as follows: Bi¼ 8p2/3hDr2ii, where the
angle brackets denote an average over MD conformations.
Biophysical Journal 98(2) 282–296some reference (average) structures, which show the confor-
mational changes on much longer timescales. The Ab17–42
dimers are characterized by less flexibility, compared to
the monomers, as clearly seen from the evolution of the
RMSDs and MSFs, and from the inspection of the MD snap-
shots. Contrary to the monomer case, some reminiscence of
the b-strand geometry and the b-sheet structure of the mature
fibril are partly preserved in the dimers on the nanosecond
timescale, mostly at the N-terminal parts of the peptides
(the origin of this asymmetry between the N- and C-termini
will be discussed below). For the Ab17–42 trimers, tetramers,
and pentamers, the plateaus attributed to the dynamically
metastable state are reached earlier in the course of MD
simulations, compared to the monomer and the dimer cases.
The conformations corresponding to the metastable states for
the tetramer and pentamer are characterized by the signifi-
cantly smaller RMSDs.
Whereas theRMSDs show structural deviations of the olig-
omers from the initial conformations in the course of MD
simulations, the MSFs provide insight into flexibility of the
oligomers. In Fig. 2 we present the MSFs of the a-carbon
atoms normalized to give the dynamic B-factors which are
used for interpretation of x-ray scattering experiments. The
analysis of the B-factors reveals few common dynamic char-
acteristics for all constructs and all oligomer sizes. As it was
anticipated (25–27,42), the N- and C-termini are the most
flexible parts of the peptides for all the systems. The enhanced
flexibility is also observed in the turn region (Ser26-Ile31) and
at the glycine residues. The inter- and intrapeptide salt bridges
between Asp23 and Lys28 residues reduce the local flexibility.
For most oligomers, the N-terminal part of the Ab17–42
peptides demonstrates the reduced flexibility compared to
the C-terminus. As we will show below, this can be attributed
to the stabilizing role of the salt bridges and also partly to the
hydrophobic attractions between residues from the central
hydrophobic cluster located at the N-terminus of the Ab17–42
peptides (residues 17–21). The increase in flexibility at the
C-terminus can be explained in part by the disruption of the
network of hydrogen bonds and resulting loss of the b-sheet
secondary structure. In the N-terminal parts of the oligomers,
the secondary structure is preserved because of the two favor-
able factors discussed above: 1), the inter- and intrapeptide
salt bridges; and 2), the hydrophobic interactions between
the residues from the central hydrophobic cluster. For the
monomers, however, the N-terminus is characterized by the
enhanced flexibility—which may indicate the tendency to
bury the hydrophobic residues in the interior of the peptide
fold.
There is an overall trend in the flexibility to increase from
the N- to C-terminus and from the left chains (solvent-
exposed Lys28 and the central hydrophobic cluster) to the
right chains (solvent-exposed Asp23) for the all models of
the Ab17–42 oligomers. At the same time, the far left chains
of the larger complexes (starting from the trimer) demon-
strate enhanced flexibility similar to that of the far right
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Thermodynamics of b-Sheet Oligomer 287chains. This observation suggests that the dissociation (and,
possibly, association) at the different edges of b-sheet Ab
aggregates and mature fibrils may follow different routes.
The asymmetry in the flexibility reflects the fact that the
salt bridges between Asp23 and Lys28 have more stabilizing
effect on the N-terminal part of the peptides in the b-sheet
oligomers, and is also the consequence of the more
pronounced hydrophobic interactions in the N-terminal
domains of the peptides. The discussed asymmetry in the
physical interactions (and resulting increase in the flexibility)
may be responsible for the observed structural twist of the
oligomers and the chirality of the protofilaments.dimer trimer tetramer pentamer
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FIGURE 4 Solvent entropic and interpeptide nonpolar contributions to
the association free energy for the wild-type Ab17–42 oligomers and the
E22Q mutants.Association thermodynamics of Ab17–42
oligomers: effects of the E22Q mutation and
protonation of Glu22
We assess thermodynamic stability of the Ab17–42 oligomers
of different size in terms of the association free energy. Aver-
aging the instantaneous values of the components of the
solvation free energy, the gas-phase internal energy, and
the conformational entropy of the peptides over the represen-
tative snapshots taken from the MD trajectories as discussed
in Methods, we obtain the estimates for the free energy of the
WT and the Dutch mutant Ab17–42 oligomers and monomers.
Then, we find the association free energy for each model as
a difference between the free energy of an oligomer and that
of constituting monomers. The association free energy and
its components for the WT oligomers at pH 7 and 4, and
for the E22Q mutants, are plotted in Figs. 3–5 as a function
of the oligomer size. As seen from Fig. 3, the association free
energy of these small b-sheet oligomers shows near-linear
trend with the dimers being thermodynamically more stable
compared to the larger complexes. The latter is in agreement
with the experimental data (93). The linear (within statistical
uncertainty) dependence of the association free energy on thedimer trimer tetramer pentamer
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FIGURE 3 Association free energy of the wild-type Ab17–42 oligomers
and the E22Q mutants as a function of their size.complex size is a consequence of the unilateral stacking of
monomers in b-sheet oligomers. Whereas for the neutral
peptides (the WT pH 4 constructs and the Dutch mutants)
such size evolution of the association free energy is an ex-
pected result, it is less obvious why the same is true for the
charged peptides with the significant contribution of the
long-rang electrostatic interactions to the association thermo-
dynamics. We will show below that this can be explained by
the complementarity between the gas-phase and solvation
electrostatic effects. It is worth mentioning that the linearity
in the association free energy is related to the b-sheet struc-
ture of the oligomers (formation of the interstrand b-sheets is
responsible for the unilateral stacking), and possible struc-
tural reconstruction of the oligomers and/or the reduction
of their b-sheet content may result in the deviation from
such behavior.dimer trimer tetramer pentamer
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FIGURE 5 Size evolution of the electrostatic part of the association free
energy for the wild-type Ab17–42 oligomers and the E22Q mutants.
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288 Blinov et al.The oligomers partially preserve their b-sheet structure in
the MD runs over the nanosecond timescale. Whereas the
structures of the monomers and the dimers significantly
depart from the initial conformations (as it follows from
the RMSDs shown in Fig. 1), the larger complexes are rela-
tively stable and keep their b-sheet structure over long time.
At the same time, the association free energy is positive for
most oligomers (the WT pH 4 Ab17–42 dimer with the neutral
charge may be an exception). This suggests that there are two
possibilities:
1. Further reconstruction of the oligomers may take place
over longer timescales, resulting in lowering of the asso-
ciation free energy; and
2. Thermodynamically stable states do not exist for small
Ab17–42 oligomers.
The latter agrees with the nucleation-polymerization mecha-
nism of the fibril formation and the existence of the critical
size of the fibrilization nucleus (1,12,13). It is worth
mentioning that the association effective energy, defined as
a sum of the solvation part of the association free energy
(including the solvation entropic component) and the associ-
ation gas-phase internal energy (71,72), remains negative for
most oligomers sizes (see Fig. S2 in the Supporting Mate-
rial). Moreover, the association effective energy decreases
with the complex size. This means that the conformational
entropy (not included in the definition of the effective energy
(71,72)) is one of the major destabilizing factors in the asso-
ciation thermodynamics of the b-sheet oligomers, and the
conformational changes in the oligomers leading toward
their stabilization may result in the reduction of the confor-
mational entropic penalty.
Our calculations demonstrate amuch lower association free
energy for the b-sheetWT oligomers at pH 4, compared to the
WT pH 7 and the E22Qmutant cases. In addition, the neutral-
ization of the peptides in acidic environments may result in
stabilization of the Ab17–42 dimers. This indicates that the
pathways of the fibrilization can be different in the lower
pH solvent environment compared to both the neutral pH
and the E22Q mutant cases. In particular, the fibrilization
through the oligomerization pathwaymay be a thermodynam-
ically favorable process, in agreement with the experimental
data (40). It was shown experimentally that the E22Q mutant
demonstrates a higher oligomerization propensity compared
to the WT pH 7 case (35–39). In our calculations, we found
no statistically significant difference between the association
free energy for the Dutch mutant and the WT pH 7 b-sheet
oligomers (see Fig. S1 for the details of the convergence
study). It may mean that the difference in the oligomerization
propensity is defined by the early stages of aggregation,
namely, the conversion of Ab monomers from the random
coil to the b-sheet conformation. The latter is in agreement
with the previous experimental and theoretical studies of the
effects of the Dutch mutation on the pathways of association
of Ab peptides, which attributed the higher oligomerizationBiophysical Journal 98(2) 282–296propensity of the mutants to a conformational transition in
the Abmonomers before the oligomerization or in the process
of the monomer deposition (17–24,31,35,37).
The E22Q oligomers have a charge distribution (on a per-
residue basis) similar to that of the WT pH 4 oligomers.
Thus, the difference in the association free energy between
the WT peptides and the E22Q mutants cannot be explained
only by the difference in the electrostatic interactions. Obvi-
ously, the reduction of the peptide charge due to mutations
or protonation of the solvent-exposed protonatable residues
at acidic conditions reduces the direct electrostatic interac-
tion between peptides. Additionally, the solvation structure
around the peptides depends on the charge distribution
which may affect both the solvation entropy (hydrophobic
interactions) and the solvation energy. To understand the
exact balance between the different physical components
of the association free energy, we decompose the association
free energy into the nonpolar gas-phase (internal) part, the
solvation entropic contribution and the electrostatic part.
The electrostatic part accounts for the direct inter-/intrapep-
tides electrostatic interactions and also includes the electro-
static component of the solvation free energy. We compare
the above physical components of the association free energy
for the WT pH 7, pH 4, and the Dutch mutant assemblies as
a function of their size in Figs. 4 and 5. For the neutral WT
peptides, the electrostatic effects, the solvation entropic
effects, and the nonpolar interactions (the gas-phase bonded
and the van der Waals interactions) all are important factors
that contribute to the lowering of the association free energy
with respect to the WT pH 7 and the E22Q cases. For the
Dutch mutants, the reduction in the direct electrostatic inter-
actions due to the E22Q substitution is mostly compensated
by the unfavorable change in the electrostatic part of the
solvation free energy (these components of the association
free energy are represented in Fig. S3). The difference in
the overall electrostatic contribution to the association free
energy between the charged WT pH 7 peptides and the
neutral E22Q mutants is within the statistical error range.
In the case of the charge neutralization due to protonation
of Glu22 residue at acidic conditions, the above compensa-
tion is not complete—which results in the lowering of the
electrostatic contribution to the association free energy for
the WT pH 4 oligomers with respect to the WT pH 7 and
the Dutch mutant cases. We also note that the charge neutral-
ization at position 22 due to protonation of Glu22 or the
E22Q mutation may alter the formation of salt bridges
between Asp23 and Lys28. This affects the contributions of
the direct (intra- and interpeptide) electrostatic interactions
between these charged residues to the association free energy
(see the discussion below). At the same time, the reduction of
the overall electrostatic penalty due to the neutralization/
substitution of Glu22 is not that significant, as it might be
expected, because it is mostly compensated by the increase
in the solvation energy. The compensation is possible
because the side chain of Glu22 is solvent-exposed and fully
Thermodynamics of b-Sheet Oligomer 289solvated in the b-sheet oligomers, much as in the proposed
models of the amyloid fibril (6–8).
The difference in the gas-phase nonpolar interactions
between the neutral WT oligomers at pH 4 and the other
constructs can be explained by the larger extent of recon-
struction of the initial structure of the oligomers in the former
case. This is a result of the destabilization of the salt bridges
between Asp23 and Lys28, which leads to more favorable
packing of the peptides in the oligomers. The favorable
reduction in the solvation entropic part of the association
free energy (directly related to the hydrophobic interactions)
upon the neutralization of the peptides is a more subtle effect.
It can be observed for both the neutral WT and (to a lesser
degree) the E22Q mutant. As we show below, the effect
can be traced-down to the modification of the microscopic
solvation structure around the peptides as a result of their
neutralization.
In addition to the obvious differences in the association
thermodynamics for different Ab17–42 complexes, there are
common basic principles behind the thermodynamic proper-
ties for all b-sheet oligomers, regardless of their charge state
or sequence. The solvation entropic effects and the interpep-
tide van der Waals interactions are the two most favorable
factors contributing to stability of oligomers. The solvation
entropic effects are directly related to the hydrophobic inter-
actions, and therefore the above results (see Fig. 4) highlight
a key role of hydrophobicity in the formation and stability of
the Ab assemblies. Fig. 4 also provides the quantitative char-
acteristics of the hydrophobic effects for the WT and Dutch
mutant Ab17–42 oligomers as a function of their size. In part,
hydrophobicity is related to the disruption of the network of
hydrogen bonds between water molecules and formation of
the hydrogen bonds between water and solute molecules—
a phenomenon fully accounted for in the framework of the
molecular theory of solvation (87). Although the hydro-
phobic interactions is a significant factor driving the process
of oligomer assembly and formation of the mature fibril, it
should be considered together with the unfavorable solvation
energetic effects in the context of thermodynamic stability of
the oligomers and fibrils under different solvent conditions.
In the gas phase (and also in nonpolar solvents or in polar
solvents at reduced density), there are no favorable hydro-
phobic interactions and, at the same time, no solvation ener-
getic penalty is present. In such situations, the energetic
balance is shifted toward the gas-phase energy and the
conformation entropy of the peptides. This can partly explain
the observation of the a-helical conformation in the MD
simulations at the reduced solvent density (18), and also
the difference in the physical properties between wet and
dehydrated fibrils.
In contrast to the favorable solvation entropic effects, the
change in the conformational entropy inhibits the association
of the peptides. This is due to the obvious reduction of flex-
ibility of a peptide upon its association with the Ab complex.
Interestingly, there is a complementarity (partial compensa-tion) between the solvation and conformational entropic
contributions for all oligomers. As a consequence, the size
evolution of the association free energy and enthalpy are
similar. Because the physical mechanisms behind the solva-
tion entropic and the conformational entropic effects are
quite different, it is a rather interesting observation.
The overall effect of the screened Coulomb interactions
(the gas-phase electrostatic interactions combined with the
electrostatic part of the solvation free energy) is to inhibit
the process of aggregation and destabilize the oligomers.
This does not exclude the favorable role of the specific
electrostatic interactions, such as hydrogen bonds and salt
bridges, which direct the formation of the oligomers and
stabilize particular elements of the secondary structure (see
the discussion of the local contributions to the free energy
and the association free energy in the next section). Impor-
tantly, the balance between the different parts of the electro-
static energy, i.e., the gas-phase and the solvation parts, can
be shifted by modification of the solvent properties such as
the level of pH or ionic strength and also by the mutations
that affect the overall charge of the peptides.
Because of the relatively short range of the van der Waals
interactions (with respect to the electrostatic interactions)
and their significant contribution to the association free
energy (Fig. 4), one can conclude that the interpeptide inter-
face in Ab oligomers with a pronounced b-sheet structure
(and also in Ab amyloid fibrils) is characterized by a high
degree of shape complementarity. This is in agreement
with the previous modeling of shorter Ab peptides (25).
Such unusually tight shape complementarity is a signature
of the dry interface of the steric zippers (5,4). It can be found
in systems characterized by the cross b-structural motif,
which is a characteristic of the Ab fibrils (6–8). The disper-
sion interactions cannot be a driving force behind aggrega-
tion at the early stages of oligomerization, when the structure
of amyloidogenic oligomers may be quite different from that
of the mature fibril (1). At these early stages, the long-range
electrostatic interactions and the hydrophobic effects are
dominant. The specific electrostatic (including hydrogen
bonding and formation of salt bridges) and hydrophobic
interactions then direct further conformational transforma-
tion toward the higher complementarity of the interpeptide
interface. At the last stages of oligomerization, the short-
range van der Waals interactions lock the b-strands in the
cross-b structures (44). This completes the formation of a
seed required for the elongation step of the fibril growth
(1,12,13).
Our calculations show that the small Ab17–42 oligomers
with the pronounced b-sheet structure have positive associa-
tion free energy, and thus they cannot be thermodynamically
stable. Major structural changes may occur in the oligomers
on the microsecond timescale and beyond, and they may lose
structural similarity with the mature amyloid fibril or disso-
ciate, as observed in some experiments (94–96). The struc-
ture of small Ab oligomers studied experimentally may beBiophysical Journal 98(2) 282–296
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290 Blinov et al.different from what one observes in relatively short MD
simulations, and the resulting balance between different
components of the association free energy may be shifted,
compared to that discussed in our study. In particular,
stability of oligomers with reduced b-sheet content can be
enhanced by a smaller conformational entropy penalty upon
their association.15 20 25 30 35 40 45
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FIGURE 6 Local electrostatic contribution to the free energy resolved on
a per-residue basis for the wild-type Ab17–42 oligomers with the charge
distributions corresponding to the solvent pH 7 (charged Glu22) and pH 4
(protonated Glu22) conditions, and for the E22Q mutant. (Top panel)
Gas-phase electrostatic contribution. (Bottom panel) Gas-phase electrostatic
energy combined with the solvation electrostatic energy. (Vertical lines)
Location of Glu22 (the WT peptides) or Gln22 (the E22Q mutants), as well
as the saltbridge-forming Asp23 and Lys28.Local contributions to the free energy
and the association free energy
The association thermodynamics and conformational
stability of the Ab17–42 oligomers can be rationalized in
terms of the local contributions of the major physical interac-
tions to the free energy. Such an approach was previously
used to study the free energy of the b-sheet dissociation in
prion proteins (97). In this section, we mainly focus on the
local direct (gas-phase) and solvation electrostatic effects
to elucidate the favorable role of the specific interactions in
the situation with the overall electrostatic penalty. The local
nonpolar effects are also briefly discussed. We resolve the
physical components of the free energy and the association
free energy on a per-residue basis. To improve statistics,
we average the data over all interior chains of the oligomers
larger than trimers. The saltbridge-forming Asp23 and Lys28
residues are exposed to solvent in the monomers and dimers,
and thus these systems should be treated separately. The
local electrostatic contributions to the free energy and the
association free energy of the b-sheet oligomers represented
in Figs. 6 and 7, respectively, show the high level of speci-
ficity related to the formation of the network of interpeptide
hydrogen bonds and the inter- and intrapeptide salt bridges
between Asp23 and Lys28.
In the N-terminal parts of the Ab17–42 peptides, the domi-
nant electrostatic contribution to the free energy is due to the
charged (in the WT pH 7 case) Glu22, Asp23 (negative
charge), and Lys28 (positive charge) residues (Fig. 6). In
the C-terminal domains, the oscillations of the electrostatic
energy associated with the formation of the hydrogen bonds
between the adjacent b-strands are clearly seen. The gas-
phase part of the electrostatic energy (Fig. 6, top panel;
note that the solvation effects are not included) shows, on
the one hand, a qualitative difference in the interactions at
position 22 between the WT pH 7 peptides, and on the other
hand, the WT pH 4 and E22Q mutant peptides. This is an
obvious consequence of the difference in the charge state
at this location. Because of the complementarity between
the direct (the gas-phase) electrostatic interactions and the
electrostatic part of the solvation free energy, it is instructive
to analyze their contributions together. We combine the gas-
phase and the electrostatic part of the solvation energy
obtained based on the generalized Born (GB) approximation,
and show the result in Fig. 6 (bottom panel). The solvation
electrostatic effects have a profound impact on the energetics
of the solvent exposed residues. In particular, a major modi-Biophysical Journal 98(2) 282–296fication of the electrostatic energy due to solvation can be
seen in the N- and C-termini for the all models, and at the
location of solvent-exposed Glu22 for the WT pH 7 oligo-
mers. A comparison of the electrostatic contributions for
the different models of the Ab17–42 oligomers shows that
the electrostatic interactions at positions 22 (the proximity
of the saltbridge-forming Asp23 residues) have the most
stabilizing effect for the Dutch mutants, followed by the
WT pH 7 and the WT pH 4 cases (Fig. 6, bottom panel).
Although there are no direct correlations between the associ-
ation thermodynamics data and the contributions of the
specific electrostatic interactions, the latter in turn signifi-
cantly affects the conformational dynamics of the oligomers
because of destabilization of the inter- and intrapeptides salt
bridges in the WT pH 4 case.
The local electrostatic contributions to the free energy,
from residues located at the different chains, strongly depend
on the degree of their exposure to the solvent. For the b-sheet
oligomers, the major differences may be between the peptide
chains located at the edges of oligomers (amyloid fibril) and in
the interior domains. In the fragment of the mature fibril used
tomodel the initial conformations for our study, theAsp23 and
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FIGURE 7 Same as in Fig. 6, but for the electrostatic contribution to the
association free energy.
Thermodynamics of b-Sheet Oligomer 291Lys28 residues form the interpeptide salt bridges (8). At the
edges of the oligomers, these charged residues are partly
exposed to solvent. This introduces the asymmetry (addition-
ally to the asymmetry in the hydrophobic interactions (8))
between the edges of the b-sheet oligomers. For small oligo-
mers, the desolvation of the charged residues due to the
disruption of the interpeptide salt bridges and the formation
of the intrapeptide ones may be an energetically favorable
process resulting in destabilization of the b-sheet structure
of the oligomers and eventually in their dissociation.
The local contributions of the different physical interac-
tions to the association free energy on a per-residue basis
can be obtained by calculating the difference between the
local energies of the oligomers and the constituting mono-
mers. The specificity of the nonbonded interactions is mostly
due to the electrostatic interactions, and we show their local
contribution to the association free energy in the top (the gas-
phase part) and the bottom (the gas-phase part combined
with the electrostatic solvation contribution) panels of
Fig. 7. Clearly, the charged Glu22 residue introduces the
local penalty toward association in the case of the WT pH 7
oligomers, and the solvation effects do not fully compensate
this unfavorable effect as it had done for the free energy. It
follows from the above comparison between the gas-phase
and the overall electrostatic contributions that the electro-
static penalty is a consequence of the partial desolvation ofGlu22 in the monomers upon their transfer from solvent to
the oligomer, rather than a result of a direct repulsion
between these charged residues. We also note that the elec-
trostatic penalty at position 22 is present for the WT pH 4
oligomers with the protonated Glu22 residues, but in the
much smaller scale, compared to the WT pH 7 case. No
such penalty is observed for the Dutch mutants, which are
characterized by the favorable electrostatic interactions both
at the position of the mutation (Gln22) and at the locations of
the saltbridge-forming residues.
It is worth noting that the pattern in the local electrostatic
interactions, on a per-residue basis for the free energy, is
robust and may be characteristic of any Ab oligomers. At
the same time, the association free energy so-resolved relies
on the conformational dynamics of the monomers. Because
the major conformational changes for the monomers are
expected beyond the nanosecond timescale, the local pattern
in the association energy discussed in this study is character-
istic of the stage of the conformational dynamics of the Ab
complexes currently accessible by MD simulations. The dis-
persion interactions resolved on a per-residue basis show a
weak trend (with the exception of the monomers case where
the interpeptide dispersion interactions are not present) of the
increase from the N- to C-terminus. It indicates a more opti-
mized packing of the side chains in the N-terminal part of the
peptides. The favorable electrostatic and hydrophobic inter-
actions between the residues in the central hydrophobic
cluster are responsible for this effect. However, the tendency
to optimize the nonbonded interactions in the N-terminal
part of the peptides introduces the internal strains in these
domains, which may overcompensate for the trend in the
dispersion interactions.Effect of charge substitution on microscopic
solvation of Ab17–42 oligomers
Neutralization of charged residues upon their protonation at
low acidic conditions or as a result of point mutation has
a significant impact on different components of the associa-
tion free energy. The effect can be direct as in the case of
the gas-phase Coulomb interactions, or can be related to the
change in the solvation structure around oligomers. In the
previous section, we have accounted for the solvent polariza-
tion effects in the framework of the generalized Born model,
as shown in the discussion of the local contributions to the free
energy and the association free energy (Figs. 6 and 7). Such
a level of theory cannot describe the nonpolar solvation
effects, and more importantly, the solvent reorganization
and related solvation entropic effects contributing to the
hydrophobicity. We have seen above that the solvation
entropy is an important factor of stability of the Ab17–42 olig-
omers. Here, we show how the Dutch mutation and proton-
ation of Glu22 affect the microscopic solvation structure
around peptides, and discuss the implications for the associa-
tion thermodynamics.Biophysical Journal 98(2) 282–296
292 Blinov et al.The complexity of the solvation shells around theWT pH 7
Ab17–42 pentamer is clearly seen from the left panel of Fig. 8.
We show there the three-dimensional solvation maps for
water oxygen (red color) and hydrogen (blue color) repre-
sented by density isosurfaces exceeding the bulk water
density by a factor of 3. The density distributions for the
solvent oxygen and hydrogen sites were obtained by using
the 3D-RISM-KH approach. Additionally to the conventional
information given by the solvent-accessible area, the three-
dimensional molecular theory of solvation provides an insight
into the balance between the oxygen and hydrogen distribu-
tions, and thus, into solvent polarization in the proximity of
peptides. The observed microscopic structure of the solvation
shells is a result of interplay between solute-solvent and
solvent-solvent interactions (including, on the one hand, the
hydrogen bonds between water molecules, and, on the other
hand, hydrogen bonds between water molecules and solute).
Local complementary in the oxygen and hydrogen distribu-
tions contributes to the lowering of the solvation free energy
by reducing the electrostatic penalty due to the solvent-solvent
interactions and also because of the reformation of the network
of hydrogen bonds between water molecules in the proximity
of the fibril. The water density around (inside) protein fold/
aggregates can easily reach a value a few times larger than
the bulk solvent density. The water molecules locked in the
high density pockets can be regarded as structural water.
The localizedwater molecules can be found inmany locations
around the oligomers and in the interior domains (see, for
example, (25,26)). Their effect on stability of the assembly of
Ab peptides will be addressed in our subsequent study. Here,
we note that the peculiarities in the solvation structure around
theWT pH 7 Ab oligomers indicate a possibility of formation
of water bridges around the glutamic acid residues, and the
water and ion channels inside the b-sheet oligomer core.
To demonstrate the effect of charge substitution on the
microscopic solvation structure of the oligomers, we showBiophysical Journal 98(2) 282–296the difference between the solvent densities corresponding
to the oxygen site of water molecule for the WT pH 7 and
the Dutch mutant pentamers in the right panel of Fig. 8.
The most dramatic changes in the solvation structure occur
at the locations of the point mutation (highlighted by the
red ellipse), and in the domains of the enhanced flexibility
(the loop domain and N- and C- termini). There is an obvious
depletion of the solvent density in the proximity of Glu22/
Gln22 residues upon the charge neutralization. This indicates
that for the Dutch mutants and also in the case of the oligo-
mers with the protonated at low pH conditions solvent-
exposed glutamic acids, the possibility of formation of the
water bridges is ruled out. If such bridges formed at neutral
pH, the above may contribute to the increase in the solvation
free energy for these models, and may reduce their local
conformation stability. It is worth mentioning that model-
ing the pH effects on thermodynamics of aggregation by
accounting the static change in the protonation states of
peptides is only an approximation that does not account for
the dynamic aspects of the equilibrium between hydrogen
ions in water and those at the protonatable residues exposed
to the solvent. The implication is that the water bridges
formed at neutral pH can delay the protonation of the
solvent-exposed residues upon lowering pH, thus affecting
the pathways of fibril formation and stability. In addition,
the presence of water bridges at normal pH may increase the
stability of the fibril formed at pH 7 relative to lower levels of
pH, as it was found in experiment (98).
Another important aspect of the microscopic solvation of
the Ab17–42 oligomers, also related to the reconstruction of
the structure of the solvation shells around peptides, is
a more favorable solvation entropic contribution to the free
energy for the Dutch mutant and the WT pH 4 oligomers,
compared to the WT pH 7 case. The effect can be traced
down to the differences in the local contributions of the
solvation entropy, TDSsolv(r), to the solvation free energyFIGURE 8 Effect of the Dutch mutation on the micro-
scopic solvation structure around the Ab17–42 pentamer.
(A) Three-dimensional solvation density map for the
wild-type pentamer represented by the isosurfaces of the
distribution functions for water oxygen (red color) and
hydrogen (blue color). Isosurfaces correspond to the water
density exceeding the bulk density value by a factor of 3.
(B) Change in the solvation structure upon the Dutch
(E22Q) point mutation shown by the isosurface of the
differential solvation density for water oxygen. Differential
density is defined as the density excess for the wild-type
oligomer with respect to that of the mutant. Isosurface
value is 0.3. (Red ellipse) Location of the charged Glu resi-
dues substituted by the neutral Gln upon the Dutch muta-
tion. Data shown is for the starting conformation used in
MD simulations. Image was produced with VMD (99).
Thermodynamics of b-Sheet Oligomer 293for the different oligomer models. We compare these con-
tributions for the wild-type Ab17–42 to the Dutch mutant
pentamer in Fig. 9. The more pronounced structure of the
solvation shells for the wild-type oligomers are in agreement
with the larger entropic contribution to the solvation free
energy clearly seen in the left panel of Fig. 9. Compared to
the Dutch mutant (Fig. 9, right panel), the major differences
come from the proximity of charged Glu22 and from the inte-
rior of the oligomer (highlighted with the red ellipse). It is
worth noting that the latter is not necessarily related to the
internal solvation of the Ab aggregates and amyloid fibrils
discussed in the previous studies (25–27). The solvation
entropy for the neutral (WT pH 4 and the Dutch mutant) olig-
omers are systematically lower compared with the WT pH 7
case for every snapshot of MD trajectory used in the calcu-
lations of the free energy. The reduction of the solvation
entropic contribution upon peptides neutralization has impli-
cation for the association thermodynamics. As seen from
Fig. 4, the solvation entropic contribution to the association
free energy is lower for the WT pH 4 oligomers (and, to
a lesser extent, for the Dutch mutants), relative to the wild-
type oligomers with the charge distribution corresponding
to neutral pH.CONCLUSIONS
Using all-atom molecular dynamics simulation and the
statistical-mechanical, three-dimensional molecular theory
of solvation (also known as 3D-RISM-KH) combined with
molecular mechanics, we have studied the association ther-
modynamics and conformational stability of small b-sheet
wild-type Ab17–42 oligomers with the different charge state
of Glu22 and the Dutch (E22Q) mutants. We have foundthat the peptide charge reduction due to the mutation or the
protonation of the solvent-exposed Glu22 results in a signifi-
cant shift of the balance between the different physical
components of the association free energy for all models.
At the same time, the overall change in the association free
energy for the E22Q mutants is relatively small, compared
to the change of the individual components of the free energy
(in this study no statistically significant difference was found
between the association free energy for the wild-type oligo-
mers at neutral pH and the E22Q mutants). This is a conse-
quence of the complementarity and the resulting partial
compensation between the direct (gas-phase) and the solva-
tion electrostatic effects. Experimentally, the E22Q mutants
demonstrate higher oligomerization propensity, compared to
the wild-type case (35–39). There is also experimental
evidence of similarities between the thermodynamics and
kinetics of aggregation of Ab1–40 peptides; note also that at
the higher aggregation rate, the Dutch Ab1–40 mutants may
be thermodynamically more stable (13). Thus, our results
suggest that the difference in the oligomerization propensity
may be defined by the early stages of aggregation, namely,
by the conversion of Ab monomers from the random coil
to the b-sheet conformation (17,18,21,24). It is worth
mentioning that our simulations were restricted to the nano-
second timescale, whereas major conformational changes
may occur in longer simulations with possible implications
for the association thermodynamics.
The association free energy of the b-sheet wild-type
Ab17–42 oligomers withGlu
22 protonated at acidic conditions,
is significantly lower, compared to both the wild-type
oligomers at neutral pH and the Dutch mutants. More-
over, small oligomers with protonated Glu22 may become
thermodynamically stable, whichmakes possible fibrilizationFIGURE 9 Effect of the Dutch mutation on the local
entropic contribution to the solvation free energy. Results
are for (A) the wild-type and (B) the Dutch mutant Ab17–42
pentamers. (Left panel, red ellipse) Contribution of the
internal domains to the entropic part of the solvation free
energy for the wild-type oligomer. Isosurfaces correspond
to the local entropic contribution to the solvation free
energy of 0.6 kcal/(mol A˚3) for the WT pH 7 model and
0.1 kcal/(mol A˚3) for the Dutch mutant. Image was
produced with VMD (99).
Biophysical Journal 98(2) 282–296
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ment with the experimental data (40). Lowering the associa-
tion free energy is related not only to the reduction of the direct
electrostatic interactions between peptides (which is largely
offset by the increase in the solvation energetic penalty), but
also to the change in the nonpolar energetics. The reason for
that is twofold.
First, there is an increase in the favorable contribution of
the dispersion interactions to the association free energy
upon the protonation of Glu22 related to more optimal
packing of the peptide side chains in the oligomers. This
may be explained by destabilization of the (transient) inter-
and intrapeptide salt bridges between Asp23 and Lys28.
Secondly, the neutralization of the solvent-exposed side
chains affects the microscopic solvation structure around
the peptides. As a result, there is a change in the solvation
entropic effects (hydrophobicity) related to the solvent
organization, additionally to the changes introduced because
of the differences in the conformational dynamics of the
oligomers at different solvent conditions. Neutralization of
peptides also eliminates the possibility of formation of water
bridges at Glu22, which may reduce the stability of the wild-
type oligomers with protonated Glu22.
In summary, for all oligomers the entropic contribution
to the solvation free energy always favors their thermody-
namic stability. The nonspecific dispersion interactions are
another important factor contributing to the stabilization of
the b-sheet oligomers. The latter is related to the high degree
of the shape complementarity and tight packing of the Ab
peptides in the b-sheet oligomers. At the same time, our
calculations revealed that the small wild-type Ab17–42
oligomers at neutral pH and the Dutch mutants with the
pronounced b-sheet structure have positive association free
energy. An implication is that in longer simulations (on
timescales of microseconds and beyond), major structural
changes may occur and oligomers may lose structural
similarity with the mature amyloid fibril or dissociate, as
observed in some experiments (94–96).SUPPORTING MATERIAL
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